Den europeiske union - norsk - EMA (European Medicines Agency)

jenson pharmaceutical services limited - dekstrometorfan, kinidin - neurobehavioral manifestations - andre nervesystemet narkotika - nuedexta er indisert for symptomatisk behandling av pseudobulbarpåvirkning (pba) hos voksne. effekt har kun blitt studert hos pasienter med underliggende amyotrofisk lateralsklerose eller multippel sklerose.

Norge - norsk - Statens legemiddelverk

curium netherlands b.v. - natriumpyrofosfat - preparasjonssett til radioaktive legemidler - 20 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - prostata neoplasmer - endokrin terapi - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Den europeiske union - norsk - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - prostata neoplasmer - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Norge - norsk - Statens legemiddelverk

upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 150 mg

Norge - norsk - Statens legemiddelverk

upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 75 mg

Norge - norsk - Statens legemiddelverk

novartis norge (2) - oktreotidacetat - injeksjons-/infusjonsvæske, oppløsning - 200 mikrog/ ml

Den europeiske union - norsk - EMA (European Medicines Agency)

amivas ireland ltd - artesunate - malaria - antiprotozoals - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. det bør vurderes å offisielle retningslinjer for riktig bruk av agenter antimalariamidler.

Norge - norsk - Statens legemiddelverk

ge healthcare b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml

Norge - norsk - Statens legemiddelverk

curium netherlands b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml